Article
Small Caps Today Oil & Gas Biotech europa oil Tooru

Small Caps Today: CelLBxHealth signs AstraZeneca services deal, Europa Oil & Gas, Tooru, Fandango, Itaconix, MedPal A and more

A landmark commercial validation headlined Friday's small-cap session, with CelLBxHealth surging nearly 46% after landing a Master Services Agreement with AstraZeneca, one of the most significant partnership announcements in the AIM biotech space this year. Elsewhere, corporate activity ranged from

by tickstock newsroom
The image features a flat-lay arrangement of seven baseball caps placed brim-down on a dark charcoal linen surface. The caps are unstructured six-panel designs in a tonal gradient, transitioning from near-black to pale warm grey, with a miniature child's cap creating a visual dip among the adult-sized caps, enhancing the disciplined composition. aiImage created using AI — nano_banana_2

A landmark commercial validation headlined Friday's small-cap session, with CelLBxHealth (AIM:CLBX) surging nearly 46% after landing a Master Services Agreement with AstraZeneca, one of the most significant partnership announcements in the AIM biotech space this year. Elsewhere, corporate activity ranged from a farm-out approval in Equatorial Guinea and a terminated acquisition to a factory accident that halted a hydrogen electrolyser programme mid-test.

CelLBxHealth named qualified AstraZeneca service provider

CelLBxHealth (AIM:CLBX) has been designated a qualified service provider to AstraZeneca under a Master Services Agreement, enabling the company to analyse clinical trial samples using its proprietary Parsortix® circulating tumour cell platform. The agreement represents a meaningful commercial endorsement of the technology, placing it directly inside one of the world's largest pharmaceutical development pipelines. Shares responded emphatically, closing at 2.52p, a gain of 46.09% on the day.

Read the story →

Fandango moves on Idaho silver property and adds director

Fandango Holdings (AIM:FHP) executed a non-binding Heads of Terms for a potential interest in an Idaho silver property, marking a fresh strategic direction for the micro-cap. Alongside the announcement, the company appointed David Facey as a Non-Executive Director with immediate effect, adding board-level resource as it pursues the deal. Shares were quoted at 0.0045p.

Read the story →

Tooru abandons Mylky acquisition over debt and legal risk

Tooru (AIM:TOO) pulled the plug on its planned purchase of Mylky, citing the deal's dependence on significant new debt and exposure to unfamiliar European legal risk as the decisive factors. The board concluded the transaction no longer served shareholders' interests on those terms. Despite the deal collapse, the shares edged 2.7% higher to 0.19p, suggesting the market welcomed the discipline.

Read the story →

Europa Oil's Antler unit wins Equatorial Guinea farm-out approval

Europa Oil & Gas (Holdings) (AIM:EOG) announced that Antler, its 42.9%-owned associate, secured Ministry for Mining and Hydrocarbons Department approval for a farm-out of the EG-08 PSC to Fuhai. Under the restructured arrangement, Antler retains a 40% working interest and the operator role, giving Europa a clear pathway to progressing the block without bearing the full cost burden. The news lifted the shares 13.33% to 1.7p.

Read the story →

Itaconix files patent for new plant-based paint platform

Itaconix (AIM:ITX) has partnered with an established specialty paint company to develop and evaluate initial plant-based paint formulations, filing both a patent application and a trademark application to protect the emerging product class. The move extends Itaconix (AIM:ITX)'s strategy of commercialising its bio-derived polymer chemistry into adjacent markets beyond its existing detergent and personal care applications. Shares rose 7.32% to 110.0p on the announcement.

Read the story →

MedPal AI posts maiden revenues with pharmacy run rate above £5m

MedPal AI (AIM:MPAL) reported its first revenues, booking £1.60m for the six months to 28 February as the company transitioned from a pre-revenue position. The pharmacy division's annualised run rate has crossed £5m, though heavy investment in the period produced a loss after tax of £3.27m. Shares added 3.37% to 2.5325p, reflecting cautious optimism around the revenue inflection.

Read the story →

Clean Power Hydrogen unit sustains serious damage in factory acceptance test

Clean Power Hydrogen (AIM:CPH2) disclosed that its MFE220 1MW membrane-free electrolyser unit sustained significant damage during the final Factory Acceptance Test at its Rossington facility. The incident has delayed completion of the unit and prompted a trading suspension while the company assesses the implications for its funding and timeline. Shares fell 1.98% to 13.6p, a relatively contained reaction given the severity of the setback, which represents a material operational blow to the programme.

Read the story →

Pulsar Helium acquires 1,360 acres to secure Jetstream #7 site

Pulsar Helium (AIM:PLSR) paid US$2.48m in cash to acquire approximately 1,360 acres of surface land at its Topaz Project in Minnesota, taking direct ownership of the area encompassing the Jetstream #7 well. The purchase removes a key tenure risk at the project and consolidates the company's control over its most advanced exploration target. Shares climbed 10.74% to 1.65p.

Read the story →

Avacta appoints Richard Hughes as non-executive chairman

Avacta Group (AIM:AVCT) named Richard Hughes as non-executive Chairman, with the appointment taking effect following the Annual General Meeting on 22 June. Hughes joins as Avacta advances its Therapeutics pipeline, bringing additional board-level oversight to a company at a critical stage of clinical development. The shares added 1.99% to 77.0p.

Read the story →

Smarter Web Company adds nine Bitcoin to treasury

Smarter Web Company (AIM:SWC) purchased nine additional Bitcoin at an average price of £54,771 each, continuing its strategy of accumulating digital assets alongside its web services operations. The acquisition adds to an existing treasury position as the company maintains its dual-track identity as both a trading business and a Bitcoin advocate. Shares were broadly flat at 29.2166p, off 0.64%.

Read the story →

European Opportunities Trust offers shareholders rollover into JPMorgan or Liontrust fund

European Opportunities Trust (LSE:EOT) agreed heads of terms for a members' voluntary winding up under section 110 of the Insolvency Act, presenting shareholders with a choice of rolling over into JPMorgan European Growth & Income or a newly established Liontrust-run LT European fund. The proposal provides a structured exit route for holders rather than a discount-laden open-market wind-down. Shares rose 3.13% to 948.8p as the market priced in the value-preserving mechanics of the deal.

Read the story →

Talisman Metals returns high-grade copper across 700m of strike at Tirzzit

Talisman Metals (AIM:TLM) released channel sampling results from its newly acquired Tirzzit Cu-Ag project, with the best intercept returning 2.65m at 1.71% Cu and 22.25ppm Ag. All seven channels sampled returned above a 0.3% Cu cut-off across 700m of strike, sitting within an interpreted 4.6km trend, a result that materially de-risks the early-stage asset. Shares gained 2.07% to 7.4p.

Read the story →

Time Out Market opens 51,000 sq ft Vancouver foodhall

Time Out Group (AIM:TMO) opened Time Out Market Vancouver, a 51,000 sq ft food and cultural market, extending its global foodhall footprint with the latest addition to the branded destination concept. The Vancouver opening continues the company's strategy of monetising the Time Out brand through physical food and entertainment venues. Shares were quoted at 7.25p.

Read the story →

Blencowe lifts Orom-Cross NPV to US$1.25bn in updated feasibility study

Blencowe Resources (AIM:BRES) published an updated Definitive Feasibility Study for its Orom-Cross graphite project in Uganda, lifting the NPV10 to US$1.254bn and raising life-of-mine free cash flow to US$4.466bn. Phase 1 and Phase 2 capital expenditure estimates were held steady, lending credibility to the revised economics rather than simply inflating the headline numbers. Shares edged 0.9% higher to 9.0p.

Read the story →

by tickstock newsroom